More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Portfolio Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Topical Cream Containing Cannabinoids

Medical Marijuana, Inc. Portfolio Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Topical Cream Containing Cannabinoids

by adminAdrianRamirez | Mar 27, 2019 | Axim Biotechnologies, Press Releases

SAN DIEGO, March 27, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its portfolio company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Participation at NoCo Hemp Expo in Denver

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Participation at NoCo Hemp Expo in Denver

by adminAdrianRamirez | Mar 26, 2019 | Press Releases

SAN DIEGO, March 26, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health today announced that it will exhibit at the NoCo Hemp Expo at the Crowne Plaza Denver Airport...
Medical Marijuana, Inc. Celebrates Company’s 10-Year Anniversary

Medical Marijuana, Inc. Celebrates Company’s 10-Year Anniversary

by adminAdrianRamirez | Mar 22, 2019 | Dixie Botanicals, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Press Releases

First Publicly-Traded Cannabis Company Observes Decade of Achievements SAN DIEGO, March 22, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the company is celebrating its...
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Medical Cannabis Event in Bahia

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Medical Cannabis Event in Bahia

by adminAdrianRamirez | Mar 18, 2019 | HempMeds Brasil, Press Releases

SAN DIEGO, March 18, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is hosting an event on Medical Cannabis at the Fera Palace Hotel in the Historic...
San Diego Union-Tribune Features Op-Ed by Medical Marijuana, Inc. CEO Discussing Hemp’s Future in the U.S. and San Diego

San Diego Union-Tribune Features Op-Ed by Medical Marijuana, Inc. CEO Discussing Hemp’s Future in the U.S. and San Diego

by adminAdrianRamirez | Mar 14, 2019 | Press Releases

SAN DIEGO, March 14, 2019  — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that an op-ed article written by the company’s CEO Dr. Stuart Titus was published in the prestigious regional...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.